Literature DB >> 3582100

Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid.

R J de Keizer, D de Wolff-Rouendaal, J L van Delft.   

Abstract

Local application of 5-Fluorouracil was practised on 5 patients. In 3 patients with multiple premalignant oculo-cutaneous lesions, two of whom had also premalignant epibulbar lesions, local 5% 5-Fu cream and/or 1% 5-Fu eyedrops were applied. In 2 other patients who had only premalignant lesions on the cornea and conjunctiva, 1% 5-Fu eyedrops were used only. In animal experiments 1% 5-Fu was not found to cause any damage to normal corneal and conjunctival epithelium. The frequency of the applications and the duration of the treatment were dependent on the location and extent of the lesions. Except for easily treatable lesions, caused by the separation of the tumour epithelium, no complications of local 5-Fu treatment were seen. The visual acuity improved in all 4 patients in whom the cornea was affected. In these premalignant conditions the diagnosis and assessment of the therapy were based on exfoliative cytology and biopsies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3582100     DOI: 10.1007/bf00166683

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  17 in total

1.  Tumors of skin. IX. Local cytostatic therapy of cutaneous and mucosal premalignant and malignant lesions.

Authors:  E Klein
Journal:  N Y State J Med       Date:  1968-04-01

2.  Topical fluorouracil. II. Postoperative administration in an animal model of glaucoma filtering surgery.

Authors:  D K Heuer; M G Gressel; R K Parrish; R Folberg; J E Dillberger; N H Altman
Journal:  Arch Ophthalmol       Date:  1986-01

3.  5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite.

Authors:  M Blumenkranz; E Hernandez; A Ophir; E W Norton
Journal:  Ophthalmology       Date:  1984-02       Impact factor: 12.079

4.  Topical fluorouracil. Pharmacokinetics in normal rabbit eyes.

Authors:  F E Fantes; D K Heuer; R K Parrish; N Sossi; M G Gressel
Journal:  Arch Ophthalmol       Date:  1985-07

5.  Ocular toxicity of fluorouracil after vitrectomy.

Authors:  W H Stern; C J Guerin; P A Erickson; G P Lewis; D H Anderson; S K Fisher
Journal:  Am J Ophthalmol       Date:  1983-07       Impact factor: 5.258

6.  Exfoliative cytology in the diagnosis of conjunctival tumours.

Authors:  P Lopez Cardozo; J A Oosterhuis; D de Wolff-Rouendaal
Journal:  Ophthalmologica       Date:  1981       Impact factor: 3.250

7.  Effects of 5-fluorouracil (5-FU) ointment on normal and diseased skin. Histological findings and deep action.

Authors:  G F Klostermann
Journal:  Dermatologica       Date:  1970

8.  Punctal-canalicular stenosis related to systemic fluorouracil therapy.

Authors:  L P Caravella; J A Burns; M Zangmeister
Journal:  Arch Ophthalmol       Date:  1981-02

9.  5-fluorouracil and glaucoma filtering surgery. II. A pilot study.

Authors:  D K Heuer; R K Parrish; M G Gressel; E Hodapp; P F Palmberg; D R Anderson
Journal:  Ophthalmology       Date:  1984-04       Impact factor: 12.079

10.  Intraocular penetration of subconjunctivally administered 14C-fluorouracil in rabbits.

Authors:  J Rootman; J Tisdall; G Gudauskas; A Ostry
Journal:  Arch Ophthalmol       Date:  1979-12
View more
  16 in total

1.  Conjunctival squamous cell neoplasia: the Liverpool Ocular Oncology Centre experience.

Authors:  N Kenawy; A Garrick; H Heimann; S E Coupland; B E Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-16       Impact factor: 3.117

2.  Orbital invasion despite topical anti-metabolite therapy for conjunctival carcinoma.

Authors:  Devron H Char; J Brooks Crawford
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-12       Impact factor: 3.117

3.  Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil.

Authors:  E Midena; C D Angeli; M Valenti; V de Belvis; P Boccato
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

4.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09

5.  5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea.

Authors:  Abdulmoghni Al-Barrag; Mutahar Al-Shaer; Nabil Al-Matary; Mohammed Al-Hamdani
Journal:  Clin Ophthalmol       Date:  2010-07-30

Review 6.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Masquerade of eyelid tumours.

Authors:  R J de Keizer; E Scheffer
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

8.  Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.

Authors:  Madhura G Joag; Adam Sise; Juan Carlos Murillo; Ibrahim Osama Sayed-Ahmed; James R Wong; Carolina Mercado; Anat Galor; Carol L Karp
Journal:  Ophthalmology       Date:  2016-03-27       Impact factor: 12.079

9.  Serial sub-conjunctival 5-Fluorouracil for early recurrent anophthalmic contracted socket.

Authors:  Saurabh Kamal; Sushil Kumar; Ruchi Goel; Sonam Angmo Bodh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-17       Impact factor: 3.117

10.  Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.

Authors:  Ibrahim O Sayed-Ahmed; Sotiria Palioura; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2016-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.